Bone Marrow Transplantation News

Minimal residual disease persistence prior to allogeneic hematopoietic stem cell transplant influenced OS and RFS among patients with acute leukemia, according to study results presented at Society of Hematologic Oncology Annual Meeting.

Hematopoietic stem cell transplantation has proved effective for the treatment of many inherited nonmalignant disorders among children.

Total body irradiation appeared to increase breast cancer risk later in life for women who underwent blood or marrow transplantation for hematologic malignancies — particularly those exposed at age 30 years or younger, study results showed.

Sorafenib maintenance therapy reduced the risk for relapse and death after hematopoietic stem cell transplantation among a subset of patients with acute myeloid leukemia, according to study results published in Journal of Clinical Oncology.

Antithymocyte globulin decreased incidence of acute graft-versus-host-disease after allogeneic stem cell transplantation from an HLA-matched sibling donor, according to randomized study results published in Journal of Clinical Oncology.

An FDA advisory committee voted 9-1 in favor of approval of the cell therapy remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease.

Achieving a “work-life balance” can seem an elusive dream.

The 62nd annual ASH Annual Meeting and Exposition will not be held in San Diego as planned.

A randomized phase 3 study designed to evaluate ruxolitinib for chronic graft-versus-host disease met its primary and key secondary endpoints.

Fox Chase Cancer Center has established a new department of bone marrow transplant and cellular therapies.